Food And Drug Administration-Colorectal Cancer Patients-Narcotic Painkillers-Healthday News

New Test Helps Evaluate Cancer Drug's Merit

MONDAY, July 9 (Healthday News) -- A new genetic test to help doctors determine if the drug Erbitux would be an effective treatment for certain colorectal cancer patients has been approved by the U.S. Food and Drug Administration. read more..

source:http://yhoo.it/MXsSEz

Teach Prescribers About Dangers of Long-Acting Pain Meds: FDA

MONDAY, July 9 (Healthday News) -- As part of its efforts to curb the abuse of narcotic painkillers, the U.S. Food and Drug Administration is requiring drug makers to educate doctors about the risks of long-acting and extended-release forms of the drugs. read more..

source:http://yhoo.it/MXsWnD

Pharmaceutical Giant-Counterfeit Version-Health Authorities-Fake Version-Cancer Drug

US finds more fake cancer drugs

A counterfeit version of Roche's cancer drug Altuzan was found to contain no active ingredient

Less than two months after counterfeit Avastin, a cancer drug made by the Swiss pharmaceutical giant Roche, was found on the US market, another fake version has turned up, health authorities said Wednesday. read more..

source:http://yhoo.it/HipfHQ

Medco Health Solutions Inc-Cancer Treatment-Effectiveness-Side Effects-Cancer Drug

Common medicines may cut cancer drug potency: study

To match Special Report PHARMA/CORRUPTION

(Reuters) - Many patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects, according to research by Medco Health Solutions Inc. For example, 43 percent of patients taking the highly effective leukemia drug Gleevec were also on another medicine that could diminish its efficacy, while 68 percent were taking something that could potentially raise the toxicity level, the study found. ... read more..

source:http://yhoo.it/zyf7iW

Food And Drug Administration-Childhood Leukemia-Healthday News-Cancer Drug

FDA Thinks Shortage of Cancer Drug for Kids Can Be Averted

TUESDAY, Feb. 14 (Healthday News) -- The U.S. Food And Drug Administration said Tuesday that it was cautiously optimistic that a feared shortage of a life-saving drug used to treat a form of childhood leukemia will be averted. read more..

source:http://yhoo.it/zUlpGg

Global Health Regulators-Supply Chain-Cancer Drug-Avastin

Fake Avastin shows very little protects drug supply

A worker makes its way on a bridge at Swiss pharmaceutical company Roche plant in Basel

NEW YORK (Reuters) - As drug counterfeiters step up their sales of bogus medicines, global health regulators have few protections in place to prevent them from reaching patients, and new laws aimed at addressing the problem could be years away. Scrutiny of the supply chain has grown since fake versions of Roche's multibillion-dollar cancer drug Avastin turned up at U.S. oncology practices late last year, sparking an international investigation that so far stretches from southern California back to Turkey with a stopover in a Cairo suburb. ... read more..

source:http://yhoo.it/z2DKNf